Pulmonary Injury after Radioactive Iodine Therapy in Pediatric Papillary Thyroid Cancer: A Case Report
Hormone Research in Paediatrics · 2023
DOI: 10.1159/000534190 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2023. Verfasst von Stephen Halada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA, haladas@chop.edu. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Introduction
Radiation-induced lung injury is a rare complication of radioactive iodine therapy (RAIT) in pediatric thyroid cancer treatment. In this case report, we describe a pediatric patient with an ERC1::RET-positive classic papillary thyroid carcinoma who developed progressive respiratory symptoms and chest imaging abnormalities following RAIT for lymph node and pulmonary disease. Case Presentation: A pediatric patient with ERC1::RET-positive classic papillary thyroid carcinoma was hospitalized for pulmonary decompensation 3 months following one empiric dose of RAIT. Testing revealed no evidence of infection or progression of pulmonary metastases, and there was no improvement with empiric antibiotic therapy for pneumonia. Despite empiric anti-inflammatory therapies, the patient remains symptomatic from a respiratory standpoint with requirement for supplemental oxygen and evidence of fibrotic changes on chest imaging.
Conclusions
This patient’s pulmonary condition is consistent with radiation-induced pulmonary injury including development of pulmonary fibrosis. With the availability of RET fusion-targeted inhibitors, this case highlights a rare pulmonary side effect of radioactive iodine for clinicians to recognize. Upfront targeted therapy protocols may help avoid radioactive iodine-associated adverse reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA, haladas@chop.edu.
- Division of Pulmonary and Sleep Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Halada, S., Leftin Dobkin, S., Baran, J. A., Sisko, L., Robbins, S. L., Rapp, J. B., Young, L. R., & Bauer, A. J. (2023). Pulmonary Injury after Radioactive Iodine Therapy in Pediatric Papillary Thyroid Cancer: A Case Report. Hormone Research in Paediatrics. https://doi.org/10.1159/000534190
Vancouver
Halada S, Leftin Dobkin S, Baran JA, Sisko L, Robbins SL, Rapp JB, et al. Pulmonary Injury after Radioactive Iodine Therapy in Pediatric Papillary Thyroid Cancer: A Case Report. Hormone Research in Paediatrics. 2023. doi:10.1159/000534190
BibTeX
@article{Halada2023,
author = {Halada, Stephen and Leftin Dobkin, Shoshana and Baran, Julia A and Sisko, Lindsay and Robbins, Stephanie L and Rapp, Jordan B and Young, Lisa R and Bauer, Andrew J},
title = {Pulmonary Injury after Radioactive Iodine Therapy in Pediatric Papillary Thyroid Cancer: A Case Report},
journal = {Hormone Research in Paediatrics},
year = {2023},
doi = {10.1159/000534190}
}
EUVIMED